Michael Spino
President at ApoPharma, Inc.
Profile
Michael Spino is currently the President of ApoPharma, Inc. since 2004.
Prior to this, he worked as the Senior Vice President-Scientific Affairs at Apotex, Inc. and as a Director at Cangene Corp.
Michael Spino active positions
| Companies | Position | Start |
|---|---|---|
ApoPharma, Inc.
 ApoPharma, Inc. Pharmaceuticals: MajorHealth Technology ApoPharma, Inc. operates as a drug company which provides drugs that helps to improve the quality of life of patients with debilitating and life-threatening diseases. It delivers and develops new molecules in 3 key areas which include hematological conditions where iron plays a role; neurodegenerative diseases; and, immune-related conditions. The company is headquartered in Toronto, Canada. | President | 01/01/2004 |
Former positions of Michael Spino
| Companies | Position | End |
|---|---|---|
| CANGENE CORPORATION | Director/Board Member | - |
Apotex, Inc.
 Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | Chief Tech/Sci/R&D Officer | - |
Experiences
Positions held
Linked companies
| Private companies | 3 |
|---|---|
Apotex, Inc.
Apotex, Inc. Pharmaceuticals: MajorHealth Technology Apotex, Inc. operates as a generic pharmaceutical company that offers medicines. It engages in research and development, bioequivalence, and clinical studies. The company was founded by Dr. Bernard Sherman in 1974 and is headquartered in Toronto, Canada. | Health Technology |
Cangene Corp.
 Cangene Corp. Pharmaceuticals: MajorHealth Technology Cangene Corp. developed, manufactured and sold biopharmaceutical drugs. The company was founded on February 22, 1984 and was headquartered in Winnipeg, Canada. | Health Technology |
ApoPharma, Inc.
ApoPharma, Inc. Pharmaceuticals: MajorHealth Technology ApoPharma, Inc. operates as a drug company which provides drugs that helps to improve the quality of life of patients with debilitating and life-threatening diseases. It delivers and develops new molecules in 3 key areas which include hematological conditions where iron plays a role; neurodegenerative diseases; and, immune-related conditions. The company is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Michael Spino
